Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CIVIK: Continuous IntraVenous Infusion of Ketamine in Terminally Ill Cancer Patients With Refractory Cancer Pain
NCT03362073Phase 2Terminated
- Sponsor
- Pusan National University Hospital
- Start
- Jun 2018
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in cancer pain, sponsored by Pusan National University Hospital. Started Jun 2018; status: terminated.
02
Drugs
ketamine
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT03362073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03362073.